- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The natural history of progressive fibrosing interstitial lung diseases ; volume:20 ; number:1 ; day:14 ; month:3 ; year:2019 ; pages:1-8 ; date:12.2019
Respiratory research ; 20, Heft 1 (14.3.2019), 1-8, 12.2019
- Urheber
-
Kolb, Martin
Vašáková, Martina
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-019-1022-1
- URN
-
urn:nbn:de:101:1-2019040715244014351350
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kolb, Martin
- Vašáková, Martina
- SpringerLink (Online service)
Ähnliche Objekte (12)
Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
Interstitial lung diseases in children
Serum biomarkers in interstitial lung diseases
Management of Fibrosing Interstitial Lung Diseases
Lung CCR6−CXCR3− type 2 helper T cells as an indicator of progressive fibrosing interstitial lung diseases
Interstitial lung diseases in the hospitalized patient
Surfactant gene polymorphisms and interstitial lung diseases
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
Progressive fibrosing interstitial lung disease: prevalence and clinical outcome
Diagnostic ability of multidisciplinary discussion in interstitial lung diseases and rare lung diseases
Lung quantitative ultrasound to stage and monitor interstitial lung diseases
Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
Interstitial lung diseases in children
Serum biomarkers in interstitial lung diseases
Management of Fibrosing Interstitial Lung Diseases
Lung CCR6−CXCR3− type 2 helper T cells as an indicator of progressive fibrosing interstitial lung diseases
Interstitial lung diseases in the hospitalized patient
Surfactant gene polymorphisms and interstitial lung diseases
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
Progressive fibrosing interstitial lung disease: prevalence and clinical outcome
Diagnostic ability of multidisciplinary discussion in interstitial lung diseases and rare lung diseases
Lung quantitative ultrasound to stage and monitor interstitial lung diseases
Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
Interstitial lung diseases in children
Serum biomarkers in interstitial lung diseases
Management of Fibrosing Interstitial Lung Diseases
Lung CCR6−CXCR3− type 2 helper T cells as an indicator of progressive fibrosing interstitial lung diseases
Interstitial lung diseases in the hospitalized patient
Surfactant gene polymorphisms and interstitial lung diseases
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
Progressive fibrosing interstitial lung disease: prevalence and clinical outcome
Diagnostic ability of multidisciplinary discussion in interstitial lung diseases and rare lung diseases